Global Companion Diagnostic Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Technology;
Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing and Other Technologies.Segmented by Indication;
Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma and Other Indications.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Companion Diagnostic Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 69.8 |
2021 | 83.0 |
2022 | 87.8 |
2023 | 102.3 |
2024 | 111.4 |
2025 | 126.2 |
2026 | 146.6 |
2027 | 162.9 |
2028 | 178.5 |
2029 | 202.4 |
2030 | 225.7 |
In the year 2023, the Global Companion Diagnostic Market was valued at USD 5,704.76 million. The size of this market is expected to increase to USD 18,918.20 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 18.7%.
Global Companion Diagnostic Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Companion Diagnostic Market |
Study Period | 2020 - 2030 |
Base Year (for Companion Diagnostic Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Companion Diagnostic Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Companion Diagnostic Market Analysis
In this report, the Global Companion Diagnostic Market has been segmented by Technology, Indication and Geography. Major tier I and tier ii businesses including roche diagnostics, agilent technologies, qiagen, thermo fisher, and abbott laboratories are involved in the companion diagnostics sector. These vendors' manufacturing locations are dispersed throughout the asia-pacific region, europe, north america, south america, and the middle east.
Global Companion Diagnostic Market, Segmentation by Technology
The Global Companion Diagnostic Market has been segmented by Technology into Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing and Other Technologies. The complete Global Companion Diagnostic Market segmentation by Technology can be seen below:
- Global Companion Diagnostic Market, By Technology
- Immunohistochemistry (IHC)
- Polymerase Chain Reaction (PCR)
- In-situ Hybridization (ISH)
- Real-time PCR (RT-PCR)
- Gene Sequencing
- Other Technologies
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Technologys mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Technology is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Companion Diagnostic Market, by Technology (USD Million), 2020 - 2030
# | Immunohistochemistry (IHC) | Polymerase Chain Reaction (PCR) | In-situ Hybridization (ISH) | Real-time PCR (RT-PCR) | Gene Sequencing | Other Technologies |
---|---|---|---|---|---|---|
2020 | 64.7 | 78.0 | 84.3 | 99.3 | 78.2 | 76.7 |
2021 | 76.7 | 80.8 | 99.7 | 100.7 | 92.1 | 86.9 |
2022 | 84.6 | 82.9 | 103.9 | 115.5 | 96.2 | 91.9 |
2023 | 97.4 | 98.8 | 104.4 | 119.7 | 105.2 | 97.3 |
2024 | 106.4 | 104.8 | 119.2 | 121.3 | 110.1 | 112.6 |
2025 | 106.4 | 122.8 | 129.0 | 124.1 | 111.6 | 129.3 |
2026 | 109.7 | 133.2 | 146.6 | 137.1 | 119.3 | 140.6 |
2027 | 127.0 | 140.4 | 156.1 | 152.9 | 140.9 | 161.6 |
2028 | 134.0 | 146.6 | 177.5 | 160.6 | 166.7 | 166.0 |
2029 | 138.8 | 161.2 | 189.5 | 181.6 | 188.1 | 198.2 |
2030 | 164.3 | 174.1 | 222.6 | 184.1 | 204.6 | 225.5 |
Global Companion Diagnostic Market, Segmentation by Indication
The Global Companion Diagnostic Market has been segmented by Indication into Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma and Other Indications. The complete Global Companion Diagnostic Market segmentation by Indication can be seen below:
- Global Companion Diagnostic Market, By Indication
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Melanoma
- Other Indications
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Indications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Indication is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Companion Diagnostic Market, by Indication (USD Million), 2020 - 2030
# | Lung Cancer | Breast Cancer | Colorectal Cancer | Leukemia | Melanoma | Other Indications |
---|---|---|---|---|---|---|
2020 | 83.9 | 54.0 | 95.9 | 83.8 | 105.0 | 87.9 |
2021 | 89.9 | 56.2 | 110.1 | 95.0 | 117.1 | 92.1 |
2022 | 93.7 | 64.3 | 123.4 | 98.1 | 129.3 | 107.9 |
2023 | 112.4 | 64.5 | 139.9 | 116.6 | 133.0 | 120.3 |
2024 | 126.0 | 71.6 | 146.3 | 128.4 | 146.3 | 142.8 |
2025 | 149.8 | 81.5 | 149.2 | 130.2 | 168.1 | 147.6 |
2026 | 161.6 | 84.1 | 169.3 | 136.5 | 174.1 | 152.7 |
2027 | 173.1 | 89.7 | 190.3 | 157.2 | 185.4 | 167.1 |
2028 | 198.3 | 100.6 | 205.9 | 182.1 | 214.7 | 188.6 |
2029 | 236.8 | 106.9 | 231.2 | 194.5 | 219.4 | 212.6 |
2030 | 244.3 | 107.5 | 241.6 | 198.1 | 254.1 | 219.2 |
Global Companion Diagnostic Market, Segmentation by Geography
In this report, the Global Companion Diagnostic Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Companion Diagnostic Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Companion Diagnostic Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Companion Diagnostic in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Companion Diagnostic Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Companion Diagnostic Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Companion Diagnostic Market will be discussed in detail in the full report.
- The new opportunities in Global Companion Diagnostic Market will be discussed in detail in the full report.
- Global Companion Diagnostic Market Drivers will be discussed in detail in the full report.
- Global Companion Diagnostic Market Restraints will be discussed in detail in the full report.
- Global Companion Diagnostic Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Companion Diagnostic Market. The opportunity map (by market segments; Technology and Indication) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Companion Diagnostic Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Companion Diagnostic Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Companion Diagnostic Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Companion Diagnostic Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. The main forces behind the signing of companion diagnostic partnerships are two pharmaceutical companies. Roche, pfizer, merck, astra zeneca, bristol-myers squibb, amgen, biogen, and eli lilly have been the most active pharmaceutical corporations. The field of companion diagnostics has seen the emergence of a number of specialised practitioners, including celera, dako, dxs, and epigenomics. Companion diagnostics for cancer according to frost & sullivan, the global companion diagnostics market is expected to reach $6.9 billion, with oncology accounting for the largest share. Explore more in the most recent analysis. The process of giving the appropriate drug at the appropriate time and dosage is known as personalised medicine. Companion diagnostics (cdx) using in vitro testing or lab produced is difficult; yet, it is crucial to demonstrate your companion diagnostic's effectiveness and usefulness. Additionally, companion diagnostics help growth products develop more quickly and cheaply for prescription drugs, can lead to better reimbursement, and can show comparative efficacy. Patients are tested as part of the diagnostics industry to find diseases. Persons who already have signs of the condition can be diagnosed, asymptomatic patients can be routinely screened, and patients with the disease can undergo ongoing testing to determine their prognosis or monitor the effectiveness of their treatment.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Companion Diagnostic Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Companion Diagnostic Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Companion Diagnostic Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Companion Diagnostic Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Companion Diagnostic Market include, Abbott Laboratories, Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Biomerieux SA, Qiagen NV, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.) and Others.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Indication
- Market Snapshot, By Region
- Market Opportunity Map
- Global Companion Diagnostic Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Companion Diagnostic Market, By Technology, 2021 - 2031 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Immunohistochemistry (IHC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- In-situ Hybridization (ISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Real-time PCR (RT-PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Gene Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Immunohistochemistry (IHC)
- Global Companion Diagnostic Market, By Indication, 2021 - 2031 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Other Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Lung Cancer
- Global Companion Diagnostic Market, By Geography, 2021 - 2031 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Brazil
- North America
- Global Companion Diagnostic Market, By Technology, 2021 - 2031 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Abbott Laboratories
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Agilent Technologies Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Biomerieux SA
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Qiagen NV
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Siemens Healthcare
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Thermo Fisher Scientific Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Danaher Corporation (Beckman Coulter Inc.)
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Others
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abbott Laboratories
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Cone Beam Imaging Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Critical Care Diagnostics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Crohn's Disease Diagnostics and Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Dental Imaging Equipment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%